Insider Transactions in Q1 2022 at Denali Therapeutics Inc. (DNLI)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 23
2022
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
20,000
-0.49%
|
$660,000
$33.77 P/Share
|
|
Feb 11
2022
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
2,918
-1.68%
|
$99,212
$34.71 P/Share
|
|
Feb 11
2022
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
2,803
-0.6%
|
$95,302
$34.68 P/Share
|
|
Feb 11
2022
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
2,560
-2.09%
|
$87,040
$34.69 P/Share
|
|
Feb 11
2022
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
9,491
-0.44%
|
$322,694
$34.72 P/Share
|
|
Feb 10
2022
|
Ryan J. Watts President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
70,749
+11.27%
|
$495,243
$7.44 P/Share
|
|
Feb 09
2022
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
1,423
-0.85%
|
$52,651
$37.1 P/Share
|
|
Feb 09
2022
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
1,423
-0.31%
|
$52,651
$37.1 P/Share
|
|
Feb 09
2022
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
2,719
-0.13%
|
$100,603
$37.55 P/Share
|
|
Feb 09
2022
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
1,296
-1.04%
|
$47,952
$37.09 P/Share
|
|
Feb 03
2022
|
Erik Harris Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,869
+50.0%
|
-
|
|
Jan 08
2022
|
Nancy Thornberry Director |
BUY
Grant, award, or other acquisition
|
Direct |
627
+19.98%
|
-
|
|
Jan 05
2022
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
2,846
-0.62%
|
$125,224
$44.77 P/Share
|
|
Jan 05
2022
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
2,845
-1.71%
|
$125,180
$44.78 P/Share
|
|
Jan 05
2022
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
2,225
-1.76%
|
$97,900
$44.75 P/Share
|
|
Jan 05
2022
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
5,007
-0.24%
|
$220,308
$44.78 P/Share
|
|
Jan 03
2022
|
Steve E. Krognes Director |
BUY
Grant, award, or other acquisition
|
Direct |
31,000
+19.71%
|
-
|
|
Jan 03
2022
|
Ryan J. Watts President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
62,000
+22.49%
|
-
|
|
Jan 03
2022
|
Carole Ho Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,000
+22.41%
|
-
|
|
Jan 03
2022
|
Alexander O. Schuth COFO and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
31,000
+20.88%
|
-
|